At the end of the experiment, spleens were harvested, and an enzyme-linked immunosorbent assay (ELISpot) was performed to analyze the cellular immune responses elicited against 4 different tumor neoepitopes described for CMT64.6 (Ndufs1, Itgav, Arghef10a.2, and Cep192A), as well as against one viral protein (E1b). This evidence concerns the gene ITGAV and neoplasm.